Julie Callison

2.8k total citations
30 papers, 1.7k citations indexed

About

Julie Callison is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Julie Callison has authored 30 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 14 papers in Epidemiology and 4 papers in Virology. Recurrent topics in Julie Callison's work include Viral Infections and Vectors (16 papers), Viral Infections and Outbreaks Research (14 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Julie Callison is often cited by papers focused on Viral Infections and Vectors (16 papers), Viral Infections and Outbreaks Research (14 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Julie Callison collaborates with scholars based in United States, Canada and United Kingdom. Julie Callison's co-authors include Heinz Feldmann, Emmie de Wit, Vincent J. Munster, Friederike Feldmann, Andrea Marzi, Hideki Ebihara, Dana Scott, Patrick W. Hanley, Cynthia Martellaro and Darryl Falzarano and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Virology.

In The Last Decade

Julie Callison

29 papers receiving 1.7k citations

Peers

Julie Callison
Greg Saturday United States
Rebecca Rosenke United States
Viktoriya Borisevich United States
Robert W. Cross United States
Olga Dolnik Germany
Elaine Haddock United States
Katrina Lythgoe United Kingdom
Wuze Ren United States
Bettina Bankamp United States
Greg Saturday United States
Julie Callison
Citations per year, relative to Julie Callison Julie Callison (= 1×) peers Greg Saturday

Countries citing papers authored by Julie Callison

Since Specialization
Citations

This map shows the geographic impact of Julie Callison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Callison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Callison more than expected).

Fields of papers citing papers by Julie Callison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Callison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Callison. The network helps show where Julie Callison may publish in the future.

Co-authorship network of co-authors of Julie Callison

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Callison. A scholar is included among the top collaborators of Julie Callison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Callison. Julie Callison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Donnell, Kyle L., Julie Callison, Heinz Feldmann, Thomas Hoenen, & Andrea Marzi. (2023). Single-Dose Treatment With Vesicular Stomatitis Virus–Based Ebola Virus Vaccine Expressing Ebola Virus–Specific Artificial Micro-RNA Does Not Protect Mice From Lethal Disease. The Journal of Infectious Diseases. 228(Supplement_7). S677–S681. 1 indexed citations
2.
Monath, Thomas P., Richard Nichols, Friederike Feldmann, et al.. (2023). Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease. Frontiers in Immunology. 14. 1216225–1216225. 13 indexed citations
3.
Haddock, Elaine, Julie Callison, Stephanie N. Seifert, et al.. (2022). Three-Week Old Pigs Are Not Susceptible to Productive Infection with SARS-COV-2. Microorganisms. 10(2). 407–407. 4 indexed citations
4.
Rosenke, Kyle, Friederike Feldmann, Eric Bohrnsen, et al.. (2022). Combined molnupiravir-nirmatrelvir treatment improves the inhibitory effect on SARS-CoV-2 in macaques. JCI Insight. 8(4). 24 indexed citations
5.
Wit, Emmie de, Friederike Feldmann, Jacqueline Cronin, et al.. (2022). Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model. EBioMedicine. 87. 104405–104405. 13 indexed citations
6.
Marzi, Andrea, Allen Jankeel, Andrea Menicucci, et al.. (2021). Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease. Frontiers in Immunology. 12. 774026–774026. 33 indexed citations
7.
Hassan, Ahmed O., Friederike Feldmann, Haiyan Zhao, et al.. (2021). A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques. Cell Reports Medicine. 2(4). 100230–100230. 81 indexed citations
8.
Rosenke, Kyle, Friederike Feldmann, Atsushi Okumura, et al.. (2021). UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates. Emerging Microbes & Infections. 10(1). 2173–2182. 13 indexed citations
9.
Munster, Vincent J., Friederike Feldmann, Brandi N. Williamson, et al.. (2020). Respiratory disease in rhesus macaques inoculated with SARS-CoV-2. Nature. 585(7824). 268–272. 434 indexed citations
10.
Marzi, Andrea, Julie Callison, Friederike Feldmann, et al.. (2019). Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge. EBioMedicine. 49. 223–231. 32 indexed citations
11.
Marzi, Andrea, Andrea Menicucci, Flora Engelmann, et al.. (2019). Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation. Frontiers in Immunology. 9. 3071–3071. 41 indexed citations
12.
Marzi, Andrea, Jackson Emanuel, Julie Callison, et al.. (2018). Lethal Zika Virus Disease Models in Young and Older Interferon α/β Receptor Knock Out Mice. Frontiers in Cellular and Infection Microbiology. 8. 117–117. 20 indexed citations
13.
Hoenen, Thomas, Andrea Marzi, Dana Scott, et al.. (2015). Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs. The Journal of Infectious Diseases. 212(suppl 2). S242–S246. 16 indexed citations
14.
Hernandez, Humberto, Caleb Marceau, Julie Callison, et al.. (2015). Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All KnownEbolavirusSpecies. The Journal of Infectious Diseases. 212(suppl 2). S410–S413. 11 indexed citations
15.
Falzarano, Darryl, Emmie de Wit, Cynthia Martellaro, et al.. (2013). Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin. Scientific Reports. 3(1). 1686–1686. 223 indexed citations
16.
Hoenen, Thomas, Allison Groseth, Julie Callison, Ayato Takada, & Heinz Feldmann. (2013). A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals. Antiviral Research. 99(3). 207–213. 45 indexed citations
17.
Marzi, Andrea, Hideki Ebihara, Julie Callison, et al.. (2011). Vesicular Stomatitis Virus–Based Ebola Vaccines With Improved Cross-Protective Efficacy. The Journal of Infectious Diseases. 204(suppl_3). S1066–S1074. 94 indexed citations
18.
Rockx, Barry, Katharine N. Bossart, Friederike Feldmann, et al.. (2010). A Novel Model of Lethal Hendra Virus Infection in African Green Monkeys and the Effectiveness of Ribavirin Treatment. Journal of Virology. 84(19). 9831–9839. 93 indexed citations
19.
Erickson, David L., Clayton O. Jarrett, Julie Callison, Elizabeth R. Fischer, & B. Joseph Hinnebusch. (2008). Loss of a Biofilm-Inhibiting Glycosyl Hydrolase during the Emergence of Yersinia pestis. Journal of Bacteriology. 190(24). 8163–8170. 45 indexed citations
20.
Callison, Julie, et al.. (2005). Characterization and expression analysis of the groESL operon of Bartonella bacilliformis. Gene. 359. 53–62. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026